Cargando…
Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8(+) tumor-infiltrating lymphocytes in ovarian cancer
Although high levels of tumor-infiltrating lymphocytes (TILs) generally correlate with good prognosis in high-grade serous ovarian cancer (HGSC) patients, little is known about the phenotype or specificity of these cells. We have recently demonstrated that TIL expressing the intra-epithelial lymphoc...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121334/ https://www.ncbi.nlm.nih.gov/pubmed/25101220 http://dx.doi.org/10.4161/onci.27668 |
_version_ | 1782329219332702208 |
---|---|
author | Webb, John R Milne, Katy Nelson, Brad H |
author_facet | Webb, John R Milne, Katy Nelson, Brad H |
author_sort | Webb, John R |
collection | PubMed |
description | Although high levels of tumor-infiltrating lymphocytes (TILs) generally correlate with good prognosis in high-grade serous ovarian cancer (HGSC) patients, little is known about the phenotype or specificity of these cells. We have recently demonstrated that TIL expressing the intra-epithelial lymphocyte marker CD103 (official name, integrin α(E), ITGAE) abundantly infiltrate HGSCs, strongly correlating with increased disease-specific survival. |
format | Online Article Text |
id | pubmed-4121334 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Landes Bioscience |
record_format | MEDLINE/PubMed |
spelling | pubmed-41213342014-08-06 Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8(+) tumor-infiltrating lymphocytes in ovarian cancer Webb, John R Milne, Katy Nelson, Brad H Oncoimmunology Author's View Although high levels of tumor-infiltrating lymphocytes (TILs) generally correlate with good prognosis in high-grade serous ovarian cancer (HGSC) patients, little is known about the phenotype or specificity of these cells. We have recently demonstrated that TIL expressing the intra-epithelial lymphocyte marker CD103 (official name, integrin α(E), ITGAE) abundantly infiltrate HGSCs, strongly correlating with increased disease-specific survival. Landes Bioscience 2014-01-10 /pmc/articles/PMC4121334/ /pubmed/25101220 http://dx.doi.org/10.4161/onci.27668 Text en Copyright © 2014 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Author's View Webb, John R Milne, Katy Nelson, Brad H Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8(+) tumor-infiltrating lymphocytes in ovarian cancer |
title | Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8(+) tumor-infiltrating lymphocytes in ovarian cancer |
title_full | Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8(+) tumor-infiltrating lymphocytes in ovarian cancer |
title_fullStr | Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8(+) tumor-infiltrating lymphocytes in ovarian cancer |
title_full_unstemmed | Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8(+) tumor-infiltrating lymphocytes in ovarian cancer |
title_short | Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8(+) tumor-infiltrating lymphocytes in ovarian cancer |
title_sort | location, location, location: cd103 demarcates intraepithelial, prognostically favorable cd8(+) tumor-infiltrating lymphocytes in ovarian cancer |
topic | Author's View |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121334/ https://www.ncbi.nlm.nih.gov/pubmed/25101220 http://dx.doi.org/10.4161/onci.27668 |
work_keys_str_mv | AT webbjohnr locationlocationlocationcd103demarcatesintraepithelialprognosticallyfavorablecd8tumorinfiltratinglymphocytesinovariancancer AT milnekaty locationlocationlocationcd103demarcatesintraepithelialprognosticallyfavorablecd8tumorinfiltratinglymphocytesinovariancancer AT nelsonbradh locationlocationlocationcd103demarcatesintraepithelialprognosticallyfavorablecd8tumorinfiltratinglymphocytesinovariancancer |